NOVEN
PHARMACEUTICALS TO PRESENT AT |
BackMiami, FL, March
3, 2004 -- Noven Pharmaceuticals, Inc. (Nasdaq: NOVN) today announced
that Robert Strauss, its President, CEO & Chairman, will present
Noven's business and prospects on Friday, March 5 at 11:15 a.m.
Eastern Standard Time at the Lehman Brothers Annual Global Healthcare
Conference. A live webcast of the presentation will be accessible to
the public at www.noven.com and at www.lehman.com/conferences/200403Healthcare,
and a rebroadcast will be available thereafter at www.noven.com.
Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a
leading developer of advanced transdermal drug delivery technologies
and prescription transdermal products. Noven’s prescription patches
are sold in over 30 countries, and a range of new patches are being
developed in collaboration with Novartis Pharma AG, Shire Pharmaceuticals
Group plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others.
With the most advanced and broadly applicable transdermal technology
in its class, Noven is committed to expanding the universe of available
transdermal therapies for the benefit of patients, partners and shareholders.
See www.noven.com for additional information.
Contact:
Investor & Media Contact
Joseph
C. Jones
Vice President – Corporate Affairs
Noven Pharmaceuticals, Inc.
(305) 253-1916
Copyright © 2004 Noven Pharmaceuticals, Inc. All rights reserved.